Overview
Stefano Mangiola practices practicing medicine in Carlton, Australia.
His clinical expertise encompasses Prostate Cancer, Brain Tumor, Lung Metastases, and Glioma.
He is actively involved in clinical research, co-authoring 42 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Stefano Mangiola
Is Stefano Mangiola a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Stefano Mangiola is classified as an Experienced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Stefano Mangiola participate in research or clinical trials?
Yes. Stefano Mangiola has published 42 articles and abstracts on conditions like Prostate Cancer. You can view a list of Stefano Mangiola's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Brain TumorMr. Mangiola isExperienced. Learn about Brain Tumor.
- GliomaMr. Mangiola isExperienced. Learn about Glioma.
- Lung MetastasesMr. Mangiola isExperienced. Learn about Lung Metastases.
- Prostate CancerMr. Mangiola isExperienced. Learn about Prostate Cancer.